Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 01/04/22 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/04/22 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 12/29/21 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 11/12/21 | Quarterly report pursuant to Section 13 or 15(d) |
|
 |
52 | |
| 11/09/21 | Current report filing |
|
|
7 | |
| 09/24/21 | Current report filing |
|
|
18 | |
| 08/13/21 | Quarterly report pursuant to Section 13 or 15(d) |
|
|
108 | |
| 08/12/21 | Current report filing |
|
7 | ||
| 08/03/21 | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
5 | ||
| 07/27/21 | Current report filing |
|
5 |